Who
Finckenstein Friedrich Graf
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Iovance Biotherapeutics.
In numbers
- Trades disclosed
- 105
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 18 Jul 2019
- Last trade
- 5 Jun 2026
- Last filed
- 9 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Jun 2026filed 9 Jun 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code M | —7,813 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code F | $17K3,976 at $4.23 | filing |
| 5 Jun 2026filed 9 Jun 2026 | IOVA Iovance Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,813 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | IOVA Iovance Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,813 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code M | —7,813 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code F | $17K3,976 at $4.23 | filing |
| 1 Jun 2026filed 3 Jun 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code M | —8,790 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code F | $18K4,473 at $3.96 | filing |
| 1 Jun 2026filed 3 Jun 2026 | IOVA Iovance Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —8,790 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | IOVA Iovance Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —8,790 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code M | —8,790 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code F | $18K4,473 at $3.96 | filing |
| 9 Mar 2026filed 11 Mar 2026 | IOVA Iovance Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —58,750 at $0.00 | filing |
| 9 Mar 2026filed 11 Mar 2026 | IOVA Iovance Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —58,750 at $0.00 | filing |
| 5 Mar 2026filed 6 Mar 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code M | —31,246 at $0.00 | filing |
| 5 Mar 2026filed 6 Mar 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code F | $76K16,520 at $4.58 | filing |
| 5 Mar 2026filed 6 Mar 2026 | IOVA Iovance Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —31,246 at $0.00 | filing |
| 5 Mar 2026filed 6 Mar 2026 | IOVA Iovance Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —31,246 at $0.00 | filing |
| 5 Mar 2026filed 6 Mar 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code M | —31,246 at $0.00 | filing |
| 5 Mar 2026filed 6 Mar 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code F | $76K16,520 at $4.58 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.